Sign in to continue:

Sunday, March 8th, 2026

ARTIUS II ACQUISITION INC. 8-K Filing Details, Entity Information & SEC XBRL Data (March 2026)

Artius II Acquisition Inc. Files 8-K: Notice of Nasdaq Non-Compliance, Working Capital Promissory Note, and Unregistered Equity Sales

Key Points from the SEC Filing:

  • Notice of Nasdaq Non-Compliance: Artius II Acquisition Inc. has received a formal notice from The Nasdaq Stock Market LLC on March 4, 2026, indicating non-compliance with Nasdaq Listing Rule 5452(a)(2)(A). The company failed to maintain a minimum of 300 public holders of its units and Class A ordinary shares, which is required for continued listing on the Nasdaq Global Market.
  • Compliance Plan and Timeline: The notice does not result in immediate delisting. The company has 45 calendar days to submit a plan to regain compliance and may be granted up to 180 calendar days to execute this plan. Artius II intends to submit its compliance plan within the required timeframe.
  • Working Capital Promissory Note: On March 6, 2026, Artius II issued a Working Capital Promissory Note to its Sponsor. The note is not registered under the Securities Act of 1933 and was issued based on Section 4(a)(2) exemption for private placements. The note gives the Sponsor rights to convert the unpaid principal into Class A common stock (or equivalent) upon a business combination, liquidation, or event of default. The conversion rate is the unpaid principal divided by \$10.00, subject to adjustments and registration rights upon business combination.
  • Unregistered Sales of Equity Securities: The issuance of the Working Capital Promissory Note constitutes an unregistered sale of equity securities, relying on a private placement exemption (Section 4(a)(2) of the Securities Act).
  • Emerging Growth Company Status: Artius II is classified as an emerging growth company and has not elected to use the extended transition period for new or revised financial accounting standards.
  • Securities Listed: The following securities are listed on Nasdaq:
    • Units (AACBU): Each consists of one Class A ordinary share (\$0.0001 par value), one right to receive one tenth of one Class A ordinary share, and one contingent right.
    • Class A ordinary shares (AACB)
    • Rights (AACBR): Each right entitles the holder to receive one tenth of one Class A ordinary share.

Price Sensitive Information & Potential Impact on Shareholders:

  • Nasdaq Non-Compliance Notice: This is a significant event that could affect the company’s trading status and investor perception. If the company fails to regain compliance, its securities could be delisted from Nasdaq, potentially impacting liquidity and share value.
  • Unregistered Equity Sales & Promissory Note: The conversion feature of the promissory note could lead to dilution for existing shareholders if exercised, especially upon a business combination or liquidation event.
  • Emerging Growth Company Status: The company benefits from reduced regulatory requirements, but investors should be aware that it may have less stringent financial reporting standards compared to non-emerging growth companies.

Details for Investors:

  • The company’s receipt of a Nasdaq non-compliance notice is not an immediate threat to its listing, but investors should monitor the company’s progress in regaining compliance. The 45-day submission window and potential 180-day remediation period are critical milestones.
  • The Working Capital Promissory Note is a financing arrangement with the Sponsor, which may be converted into shares at a \$10.00 per share rate. Such conversions may dilute shareholder ownership, especially in the context of a business combination or liquidation.
  • The company’s securities (AACBU, AACB, AACBR) remain listed on Nasdaq for now. If delisting occurs, it could reduce liquidity and possibly cause downward pressure on share prices.
  • Shareholders should pay attention to the company’s future filings regarding compliance, business combinations, and any additional unregistered equity transactions.

Conclusion:
The filing contains multiple items that are potentially price sensitive, notably the Nasdaq non-compliance notice and the convertible promissory note. Investors are advised to monitor developments regarding compliance with Nasdaq listing requirements, as well as any future equity issuances or business combination events that may impact share value and ownership structure.


Disclaimer:
This article is based on information extracted from the SEC filing and is intended for informational purposes only. It does not constitute investment advice. Investors should conduct their own due diligence and consult professional advisers before making investment decisions. The company’s future actions, regulatory compliance, and market conditions may significantly affect the value of its securities.

View Artius II Acquisition Inc. Historical chart here



Applied Optoelectronics Signs 130-Month Lease for 153,928 Sq Ft Facility at Blue Ridge Commerce Center, Houston, TX

Applied Optoelectronics Signs Major Long-Term Lease in Houston Applied Optoelectronics Announces Major Long-Term Lease: Key Details for Investors Applied Optoelectronics, Inc. (NASDAQ: AAOI) has announced the signing of a significant lease agreement that could...

Black Hawk Acquisition Corporation 2024 Annual Report – Business Combination, Management, Strategies, and Financial Overview

Black Hawk Acquisition Corporation 10-K Analysis: Key Investor Insights Black Hawk Acquisition Corporation 10-K: Detailed Investor Analysis Overview Black Hawk Acquisition Corporation, a blank check company incorporated in the Cayman Islands on September 28,...

Lyra Therapeutics, Inc. 8-K Filing February 2026: Company Information, Nasdaq Listing, and Entity Details

Lyra Therapeutics Receives Default Notice Amid Wind-Down and Potential Bankruptcy Risks Lyra Therapeutics Receives Default Notice Amid Wind-Down and Potential Bankruptcy Risks Key Developments and Investor Implications from the Latest 8-K Filing Lyra Therapeutics,...

   Ad